Log In
Print
BCIQ
Print
Print this Print this
 

CGEN-15001

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionFusion protein combining an Fc antibody fragment with the extracellular region of a previously unknown membrane protein in the B7/CD28 family
Molecular Target T cell activation RhoGTPase activating protein (TAGAP)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today